期刊文献+

特发性青少年骨质疏松症 被引量:5

下载PDF
导出
摘要 特发性青少年骨质疏松症(IJO)发生在青春前期,严重者可出现长骨干骺端骨折和椎体的双凹变形。IJO的诊断必须排除各种原因尤其是成骨不全引起的继发性骨质疏松。IJO患者的症状在青春期后可以自行缓解。IJO的发病机制仍不十分清楚,可能与成骨细胞或破骨细胞功能障碍,胶原合成异常及青春期的快速生长有关系。
作者 姜艳
机构地区 中国医学科学院
出处 《国外医学(内分泌学分册)》 2003年第2期139-141,共3页 Foreign Medical Sciences(Section of Endocrinology)
  • 相关文献

参考文献10

  • 1Rauch F, Travers R, Norman M E, et al. Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellousbone[J].J Bone Miner Res,2000,15:957 -963.
  • 2Cassidy J T. Osteopenia and osteoporosis in children[J].Clin Exp Rheumatol,1999,17:245 -250.
  • 3Villaverde V, Inocencio J D, Menrino R, et al. Difficulty walking. A presentation of idiopathic juvenile osteoporosis[J].J Rheumat,1998,25:173- 176.
  • 4Rauch F, Travers R, Norman M E, et al.The bone formation defect in idiopathic juvenile osteoporosis is surface specific[J].Bone,2002,31:85 -89.
  • 5Dawson P A, Kelly T E, Marini J C. Extension of pheno type associated with structural mutations in type I collagen: siblings with juvenile osteoporosis have an alpha2(I)Gly436→Arg substitution[J].J Bone Miner Res,1999,14:449 -455.
  • 6Lornc R S. Idiopathic juvenile osteoporosis[J].Calcif Tissue Int,2002,70:395- 397.
  • 7Boot A M, Ridder M, Pols H, et al. Bone mineral density in children and adolescents: Relation to puberty, calcium intake and physical activity[J].J Clin Endocrinol Metab,1997,82:57 -62.
  • 8Allgrove J. Biphosphonates[J].Arch Dis Child,1997,76:73 -75.
  • 9Shaw N J, Boivin C M, Crabtree N J. Intravenous pamidronate in juvenile osteoporosis[J].Arch Dis Child,2000,83:143 -145.
  • 10Bianco P, Robey P G. Disease of bone and the stromal cell lineage[J].J Bone Miner Res,1999,14:336 -341.

同被引文献87

  • 1谭登,张玉,张农山,刘军,万仕炜,韩龙,方彭华,闵文.补肾通络方对骨质疏松斑马鱼效应评价及破骨细胞自噬机制[J].中国实验方剂学杂志,2020,0(7):79-85. 被引量:18
  • 2李险峰.骨质疏松症的分类和分型[J].中国全科医学,2005,8(16):1300-1300. 被引量:11
  • 3靳梅梅,赵晋萍,席卫平,杨建平,张佩瑛,李思汉,马克己,白珠蒂,郭金枝,徐强(编校).维生素D缺乏性佝偻病的发病原因与相关因素的探讨[J].中国妇幼保健,2007,22(16):2217-2218. 被引量:6
  • 4CHEUNG M S,GLORIEUX F H.Osteogenesis Imperfecta:update on presentation and management[J].Rev Endocr Metab Disord,2008,9(2):153-160.
  • 5SILLENCE D O,RIMOIN D L.Classification of osteogenesis imperfect[J].Lancet,1978,1(8072):1041-1042.
  • 6RAUCH F,GLORIEUX F H.Osteogenesis imperfecta[J].Lancet,2004,363(9418):1377-1385.
  • 7CABRAL W A,CHANG W,BARNES A M,et al.Prolyl 3-hydroxylase1deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta[J].Nat Genet,2007,39(3):359-365.
  • 8CHEUNG M S,GLORIEUX F H.Osteogenesis Imperfecta:update on presentation and management[J].Rev Endocr Metab Disord,2008.9(2):153-160.
  • 9KIM H J,RICE D P,KETTUNEN P J,et al.FGF-,BMPand Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development[J].Development,1998,125(7):1241-1251.
  • 10MARINI J C,FORLINO A,CABRAL W A,et al.Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen:regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans[J].Hum Mutat,2007,28(3):209-221.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部